| pubmed-article:20804464 | pubmed:abstractText | ? A hypoallergen of the major cat allergen Fel d 1, recombinant (r) Fel d 1 (DTE III), was previously shown to have retained T-cell reactivity and strongly reduced IgE-binding capacity compared to unmodified rFel d 1. Here, we evaluated the therapeutic capacity of rFel?d 1 (DTE III) in a mouse model for cat allergy. | lld:pubmed |
